163 related articles for article (PubMed ID: 7811045)
21. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors.
Gordon SM; Carlyn CJ; Doyle LJ; Knapp CC; Longworth DL; Hall GS; Washington JA
Ann Intern Med; 1996 Sep; 125(6):465-70. PubMed ID: 8779458
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
Dan M; Poch F; Sheinberg B
Antimicrob Agents Chemother; 2002 Jun; 46(6):1671-3. PubMed ID: 12019074
[TBL] [Abstract][Full Text] [Related]
23. Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
Carlyn CJ; Doyle LJ; Knapp CC; Ludwig MD; Washington JA
Antimicrob Agents Chemother; 1995 Jul; 39(7):1606-8. PubMed ID: 7492114
[TBL] [Abstract][Full Text] [Related]
24. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
[TBL] [Abstract][Full Text] [Related]
25. Quinolone-resistant Neisseria gonorrhoeae in Hong Kong.
Kam KM; Wong PW; Cheung MM; Ho NK; Lo KK
Sex Transm Dis; 1996; 23(2):103-8. PubMed ID: 8919735
[TBL] [Abstract][Full Text] [Related]
26. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
Martin I; Jayaraman G; Wong T; Liu G; Gilmour M;
Sex Transm Dis; 2011 Oct; 38(10):892-8. PubMed ID: 21934558
[TBL] [Abstract][Full Text] [Related]
27. Molecular epidemiology of Neisseria gonorrheae isolates with plasmid-mediated tetracycline resistance in Canada: temporal and geographical trends (1986-1997).
Greco V; Ng LK; Catana R; Li H; Dillon JA
Microb Drug Resist; 2003; 9(4):353-60. PubMed ID: 15000741
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic susceptibility patterns and plasmid profiles of penicillinase-producing Neisseria gonorrhoeae strains in Durban, South Africa, 1990-1993.
Chenia HY; Pillay B; Hoosen AA; Pillay D
Sex Transm Dis; 1997 Jan; 24(1):18-22. PubMed ID: 9018779
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
30. Characterization of an outbreak of tetM-containing Neisseria gonorrhoeae in Argentina.
Fernandez Cobo M; Galarza P; Sparo M; Buscemi L; Pizarro MR; Fiorito S
Int J STD AIDS; 1999 Mar; 10(3):169-73. PubMed ID: 10340197
[TBL] [Abstract][Full Text] [Related]
31. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Melby K; Faegri A
APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Neisseria gonorrhoeae in Ontario, Canada, with decreased susceptibility to quinolones by pulsed-field gel electrophoresis, auxotyping, serotyping and plasmid content.
Harnett N; Brown S; Riley G; Terro R; Krishnan C; Pauzé M; Yeung KH
J Med Microbiol; 1997 May; 46(5):383-90. PubMed ID: 9152033
[TBL] [Abstract][Full Text] [Related]
33. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.
Kam KM; Lo KK; Ho NK; Cheung MM
Genitourin Med; 1995 Jun; 71(3):141-4. PubMed ID: 7635487
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P;
Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Jiang FX; Lan Q; Le WJ; Su XH
BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
[TBL] [Abstract][Full Text] [Related]
36. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
37. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.
Dillon JA; Rubabaza JP; Benzaken AS; Sardinha JC; Li H; Bandeira MG; dos Santos Fernando Filho E
Sex Transm Dis; 2001 Sep; 28(9):521-6. PubMed ID: 11518869
[TBL] [Abstract][Full Text] [Related]
38. Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994. What was the impact of ciprofloxacin as first-line therapy for gonorrhea?
Zenilman JM
Sex Transm Dis; 1996; 23(3):213-8. PubMed ID: 8724511
[TBL] [Abstract][Full Text] [Related]
39. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance of Neisseria gonorrhoeae in Liberia.
Guyot A; Jarrett B; Sanvee L; Dore D
Trans R Soc Trop Med Hyg; 1998; 92(6):670-4. PubMed ID: 10326119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
